Allied Corp ALID
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.16
- Day Range
- $0.15–0.16
- 52-Week Range
- $0.02–0.32
- Bid/Ask
- $0.13 / $0.18
- Market Cap
- $17.14 Mil
- Volume/Avg
- 3,100 / 16,590
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 725.23
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Allied Corp is an international cannabis company with a mission to help people suffering from Post-Traumatic Stress Disorder (PTSD) by researching, creating, and producing targeted cannabinoid health solutions. The company uses an evidence-informed scientific approach to make this mission possible through cutting-edge pharmaceutical research and development, plant-based production, and the development of therapeutic products. The company operates in two segments which include Allied and Allied Colombia. Its geographical segments consist of Colombia and Canada. The company’s revenue is comprised ofsales ofcannabis products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 150
- Website
- https://www.allied.health
Valuation
|
Metric
|
ALID
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 725.23 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ALID
|
|---|---|
Quick Ratio | 0.03 |
Current Ratio | 0.08 |
Interest Coverage | −9.28 |
Quick Ratio
ALID
Profitability
|
Metric
|
ALID
|
|---|---|
Return on Assets (Normalized) | −106.47% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −228.11% |
Return on Assets
ALID
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Mvxptwxjs | Jnmsgx | $70.8 Bil | |
ZTS
| Zoetis Inc Class A | Crwhrktyph | Hhhz | $68.9 Bil | |
HLN
| Haleon PLC ADR | Ngffgbmtk | Xjxt | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Bwpkbfh | Yhg | $14.8 Bil | |
VTRS
| Viatris Inc | Dmtbpcj | Ycc | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Rjklhcywf | Kcht | $11.9 Bil | |
CTLT
| Catalent Inc | Hprjyzcx | Rgtnbr | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Bnphxvhb | Wflbc | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Tzgxmzs | Myww | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wggzysc | Xjkgsmv | $3.5 Bil |